4 recruiting, 1 terminated, 1 withdrawn. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 4, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Prostate Cancers: new trials by email Literature Review of Prostate Cancers trials Research Report on Prostate Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using FAPI PET/MRI to Evaluate Prostate Cancer FAPI, Positron Emission Tomography (PET), Magnetic Resonance Imaging - Prostate Cancer Metastatic Disease, Prostate Cancers | Phase 2 | Recruiting | University of Wisconsin, Madison | 30 | 2026-02-27 | 2026-06-10 |
| Early Phase Study of KESONOTIDE™in Participants With Solid Tumours A novel hGIIA-Vimentin Inhibitor, Dose expansion - Prostate Cancers, Breast Cancer | Phase 1 / Phase 2 | Recruiting | Filamon LTD | 80 | 2025-11-07 | 2026-03-17 |
| Ivonescimab in the Treatment of Multiple Advanced Tumors Ivocizumab - Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma | Phase 2 | Recruiting | Fudan University | 400 | 2024-11-20 | 2025-08-24 |
| FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer FK-PC101, Standard of Care (SOC) - Prostate Cancer (Adenocarcinoma), Prostate CA | Phase 2 | Recruiting | Cellvax Therapeutics Inc | 100 | 2024-10-14 | 2024-10-21 |
| Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management 68Ga-(HBED-CC)-PSMA - Prostate Cancers | Phase 2 | Withdrawn | Jules Bordet Institute | 2016-10-01 | 2017-08-22 | |
| FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cancer anti [18F]FACBC - Prostate Cancers | Phase 2 | Terminated | David M. Schuster, MD | 11 | 2008-04-01 | 2014-01-07 |
Prostatic Neoplasms (6) · Adenocarcinoma (1) · Angiomyolipoma (1) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Basal Cell (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Transitional Cell (1) · Glioblastoma (1) · Kidney Neoplasms (1) · Lung Neoplasms (1) · Ovarian Neoplasms (1) · Paget Disease, Extramammary (1) · Pancreatic Neoplasms (1) · Paraganglioma (1)
Genital Diseases (6) · Genital Diseases, Male (6) · Genital Neoplasms, Male (6) · Male Urogenital Diseases (6) · Neoplasms (6) · Neoplasms by Site (6) · Prostatic Diseases (6) · Urogenital Diseases (6) · Urogenital Neoplasms (6) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2)
68Ga-DKFZ-PSMA-11 (1) · Magnetic Resonance Spectroscopy (1) · Standard of Care (1) · fluciclovine F-18 (1) · gallium 68 PSMA-11 (1)
Cellvax Therapeutics Inc (1) · David M. Schuster, MD (1) · Filamon LTD (1) · Fudan University (1) · Jules Bordet Institute (1) · University of Wisconsin, Madison (1)
United States (3) · Australia (1) · China (1)
Ali Pirasteh, MD (1) · Carlos Artigas, MD (1) · David M Schuster, MD (1) · Fernando Kreutz, MD PhD (1) · Hongxia Wang, Doctor (1)